Julian Robertson Adaptive Biotechnologies Corp Transaction History

Tiger Management L.L.C.

  • $22.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$6.4 - $14.73 $3.77 Million - $8.68 Million
-589,311 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$10.12 - $28.9 $5.32 Million - $15.2 Million
-526,100 Reduced 47.17%
589,311 $8.18 Million
Q3 2019

Nov 14, 2019
BUY
$30.31 - $53.51 $33.8 Million - $59.7 Million
1,115,411 New
1,115,411 $34.5 Million

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
144M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.11B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track Julian Robertson's Portfolio

Track Julian Robertson Portfolio

Follow Julian Robertson (Tiger Management L.L.C.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiger Management L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Tiger Management L.L.C. and Julian Robertson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email